Kailera Therapeutics Inc is a United States-based company. The Company is a clinical-stage biopharmaceutical company developing a broad and advanced therapeutic pipeline that is poised to deliver differentiated treatment options for obesity and related conditions. Its pipeline consists of clinical- and preclinical-stage programs with injectable peptides, oral peptides, and an oral small molecule.
종목 코드 KLRA
회사 이름Kailera Therapeutics Inc
상장일Apr 17, 2026
CEORenaud (Ron)
직원 수- -
유형Ordinary Share
회계 연도 종료- -
주소180 Third Ave
도시WALTHAM
증권 거래소NASDAQ OMX - NASDAQ BASIC
국가United States of America
우편 번호02451
전화15084409475
웹사이트https://www.kailera.com
종목 코드 KLRA
상장일Apr 17, 2026
CEORenaud (Ron)